patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
alirocumab
Marketedupdated 2mo agoby Sanofi-Aventis US LLC
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 6 investigational indications.
indications
investigational
Hyperlipidemia
all catalysts(14)
approval · 14
News(3)
- Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
- STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and morePresident Trump heralded a drug-pricing agreement with Regeneron, closing the last of 17 deals sought by the White Housestat · 2mo ago
- STAT+: Trump celebrates closing first round of drug pricing deals, promises more aheadA deal with Regeneron was the last of 17 initially sought by the White House.stat · 2mo ago
comments(0)
5-min edit window · permanent after that